MDxHealth is trading 5.09% down at $0.52, with no clear, directly connected catalyst identified.
- Its press-release page shows no September 29 announcement and does not identify a catalyst for the decline.
- Its latest listed results, released August 13, reported second-quarter revenue growth of 16% to $27.2 million.
- Broader-market moves were mixed and modest, providing no established market-wide explanation for the drop.